Triple negative breast cancer: the role of metabolic pathways.
This article reviews some of the metabolic pathways and biomarkers which have been shown to be aberrantly expressed in triple negative breast cancer and highlights some of the ongoing work in this area.
PMID: 25500513 [PubMed - indexed for MEDLINE]
Source: Malaysian Journal of Pathology - Category: Pathology Tags: Malays J Pathol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Diabetes | Eating Disorders & Weight Management | Endocrinology | HER2 | Hormones | Malaysia Health | Metabolic Syndrome | Obesity | Pathology | Women